Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Here, the association of 1,25(OH)2D and PTH(1 to 84) levels was evaluated for prediction of cardiovascular death in chronic HF patients.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
1,25-Dihydroxyvitamin D to PTH(1 to 84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
Study design awaiting verification · PLoS ONE · 2015
Original publication title
1,25-Dihydroxyvitamin D to PTH(1 to 84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
© 2015 Gruson et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Vitamin D deficiency and hyperparathyroidism are common in patients with heart failure (HF). There is a growing body of evidence supporting the role of vitamin D and parathyroid hormone (PTH) in cardiac remodeling and worsening of HF. Lack of reliable automated testing of 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active metabolite of vitamin D, has limited its contribution to the prognostic assessment of HF. Here, the association of 1,25(OH)2D and PTH(1 to 84) levels was evaluated for prediction of cardiovascular death in chronic HF patients.
Source: ObjectivesAbstract: What methods does the paper describe?
We conducted a single center prospective cohort including 170 chronic HF patients (females n = 36; males n = 134; NYHA II-IV; mean age: 67 years; etiology: ischemic n = 119, dilated cardiomyopathy n = 51; mean LVEF: 23%). The primary outcome was cardiovascular death.
Source: MethodsAbstract: Results
Serum levels of 1,25(OH)2D decreased markedly with increased HF severity. Medians were 33.3 pg/mL for NYHA-II patients, 23.4 pg/mL for NYHA-III, and 14.0 pg/mL for NYHA-IV patients (p<0.001). Most patients had levels of 25(OH)D below 30ng/mL, and stratification by NYHA functional class did not show significant differences (p = 0.249). The 1,25(OH)2D to PTH(1 to 84) ratio and the (1,25(OH)2D)2 to PTH(1 to 84) ratio were found to be the most significantly related to HF severity. After a median follow-up of 4.1 years, 106 out of 170 patients reached the primary endpoint.
Cox proportional hazard modeling revealed 1,25(OH)2D and the 1,25(OH)2D to PTH(1 to 84) ratios to be strongly predictive of outcomes.
Source: ResultsAbstract: Conclusions
1,25(OH)2D and its ratios to PTH(1 to 84) strongly and independently predict cardiovascular mortality in chronic HF.
Source: ConclusionsAuthors’ abstract
Objectives
Vitamin D deficiency and hyperparathyroidism are common in patients with heart failure (HF). There is a growing body of evidence supporting the role of vitamin D and parathyroid hormone (PTH) in cardiac remodeling and worsening of HF. Lack of reliable automated testing of 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active metabolite of vitamin D, has limited its contribution to the prognostic assessment of HF. Here, the association of 1,25(OH)2D and PTH(1 to 84) levels was evaluated for prediction of cardiovascular death in chronic HF patients.
Methods
We conducted a single center prospective cohort including 170 chronic HF patients (females n = 36; males n = 134; NYHA II-IV; mean age: 67 years; etiology: ischemic n = 119, dilated cardiomyopathy n = 51; mean LVEF: 23%). The primary outcome was cardiovascular death.
Results
Serum levels of 1,25(OH)2D decreased markedly with increased HF severity. Medians were 33.3 pg/mL for NYHA-II patients, 23.4 pg/mL for NYHA-III, and 14.0 pg/mL for NYHA-IV patients (p<0.001). Most patients had levels of 25(OH)D below 30ng/mL, and stratification by NYHA functional class did not show significant differences (p = 0.249). The 1,25(OH)2D to PTH(1 to 84) ratio and the (1,25(OH)2D)2 to PTH(1 to 84) ratio were found to be the most significantly related to HF severity. After a median follow-up of 4.1 years, 106 out of 170 patients reached the primary endpoint.
Cox proportional hazard modeling revealed 1,25(OH)2D and the 1,25(OH)2D to PTH(1 to 84) ratios to be strongly predictive of outcomes.
Conclusions
1,25(OH)2D and its ratios to PTH(1 to 84) strongly and independently predict cardiovascular mortality in chronic HF.
Publication and source details
Original title: 1,25-Dihydroxyvitamin D to PTH(1 to 84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
Damien Gruson; Benjamin Ferracin; Sylvie A. Ahn; Claudia Zierold; Frank Blocki; Douglas M. Hawkins; Fabrizio Bonelli; Michel F. Rousseau
PLoS ONE · 2015
Competing Interests: Claudia Zierold, Frank Blocki, and Fabrizio Bonelli are employees of DiaSorin Inc., a provider of in vitro diagnostic products. For the current study, their contribution was to provide advice for the best use and monitoring of novel assays and scientific input for results interpretation as well as editing of manuscript. The authors are also working on a provisional patent. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: DG DH F. Bonelli CZ F. Blocki MR. Performed the experiments: DG BF SA DH MR. Analyzed the data: DG SA DH F. Bonelli CZ F. Blocki MR. Contributed reagents/materials/analysis tools: DG BF SA DH F. Bonelli CZ F. Blocki MR. Wrote the paper: DG SA DH F. Bonelli CZ F. Blocki MR.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:31:27.362805+00:00
DOI: 10.1371/journal.pone.0135427 · PMC4550259